Scientists from Duke-NUS Medical School (Duke-NUS) at Singapore have developed a new approach using the Zika virus to de...
Taiwan-based BioGate Precision Medicine Corp., a member of Powerchip Group, has unveiled an innovative breakthrough in p...
Epsilogen, a leading immunoglobulin E (IgE) antibodies developer treating cancer, and global biopharma leader Lonza have...
In a breakthrough for personalised oncology, scientists from the National University of Singapore (NUS) and the National...
A collaborative research team from the Department of Chemical Engineering and the School of Convergence Science and Tech...
Could you give us an overview of the GHIT Fund's mission and how it originated? The idea for the GHIT (Global Health In...
Orthohantaviruses, highly transmissible zoonotic pathogens, are notorious for causing haemorrhagic fever with renal synd...
As the world marks Cancer Awareness Month, Malaysia has made significant strides in the field of cancer treatment, earni...
Daiichi Sankyo, an innovative global healthcare company, has launched its subsidiary Daiichi Sankyo Singapore ...
China's AffaMed Therapeutics, has obtained New Drug Application (NDA) from Singapore Health Sciences Authority (HSA...
The Australian government is providing $50 million to develop and commercialise the world’s most advanced artifici...
Japan headquartered Astellas Pharma and US-based biotech startup Kelonia Therapeutics have announced a collaborative eff...
A joint multi-disciplinary team from The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine...
According to the World Health Organization (WHO), approximately 2.5 billion people worldwide are estimated to have some ...
The University of Texas MD Anderson Cancer Center in the US, and South Korea-based startup C-Biomex have announced ...
Recce Pharmaceuticals Limited, the Company developing a New Class of Synthetic Anti-Infectives, has signed Memorand...
Imagine a world where a non-invasive breast cancer test delivers results within 15 minutes, costing less than half the p...
Rare diseases, often overlooked, affect a significant portion of the global population. However, early detection and int...
Sysmex Corporation and Hitachi High-Tech Corporation are collaborating to develop novel genetic testing systems based on...
AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell the...
The Australian government is funding a wide-ranging national research programme that will give new hope and help to Aust...
Researchers led by Nanyang Technological University, Singapore (NTU Singapore) have developed a new and precise way to t...
The 16th Obstetrics and Gynaecology Conference took place on 30 January under the theme ‘From evidence to practice...
The previous year witnessed many promising developments in the fight against rare diseases. The recent Casgevy’s F...
The field of Antibody-Drug Conjugates (ADCs) has experienced a remarkable transformation, shifting from dormancy to a su...
Cancer poses a significant challenge for the pharmaceutical industry, driving a constant search for improved oncology dr...
Lung cancer is the leading cause of cancer deaths in Hong Kong and worldwide, but there is still an unmet clinical need ...
AbbVie expanded its Singapore manufacturing facility on 25th Jan, strengthening its manufacturing capabilities. With a n...
An international study led by the National Cancer Centre Singapore (NCCS) and Duke-NUS Medical School has effectively ta...
A team of scientists from Nanyang Technological University, Singapore (NTU Singapore) has demonstrated that commun...
Projections by the International Agency for Research on Cancer estimate 15.1 million new cases per year, until 2040. Thi...
US-based Vertex Pharmaceuticals Incorporated has announced that the Saudi Food and Drug Authority (SFDA) has g...
The Centre for Chinese Herbal Medicine Drug Development of Hong Kong Baptist University (HKBU) has develo...
Kite Pharma, a Gilead Company, is a global biopharmaceutical company specializing in cancer cell therapy As the global c...
GYSS 2024 is celebrating the values of science promoting collaboration and teamwork in Singapore from 8 to 12 January 20...
Denmark headquartered Novo Nordisk Foundation is committing up to $25 million to support the early-stage devel...
China-based startup SanReno Therapeutics, a clinical-stage company specializing in the discovery, development...
A research team from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of S...
Changchun GeneScience Pharmaceutical (GenSci), a subsidiary of Changchun High-Tech Industries (Group), recently held a g...
Singapore-based biotech startup ImmunoScape has announced a partnership with the Experimental Drug Development Centre (E...
Austrianova, a member of the SGAustria group of companies, and a leading provider of cell encapsulated products as well ...
Scientists led by Duke-NUS Medical School in Singapore and the University of California, Los Angeles, (UCLA) in the Un...
An international team of researchers, led by Pfizer in collaboration with Monash University and the Australian-based Can...
Assistant Professor Cheow Lih Feng from the National University of Singapore's (NUS) Institute for H...
Medlab Middle East, the region's largest medical laboratory exhibition, will bring together leading researchers in NextG...
Scientists from Duke-NUS Medical School (Duke-NUS) in Singapore and their collaborators have come up with new methods to...
The multi-target research and development partnership will focus on severe skin diseases • &nbs...
In a world-first, researchers at the Royal Adelaide Hospital (RAH) and the University of Adelaide in Australia are seeki...
The third edition of the "Asia Pacific Forum on Precision Cancer Treatment" concluded today with a dynamic exchange of i...
Devmanyu Singh, Integrated Health Solution Lead at Roche, takes center stage at the Asia Pacific Forum on Precis...
National Heart Centre Singapore (NHCS) has partnered with US-based Medera’s Novoheart to create the world’s ...
Cervical cancer presents a paradoxical situation. It is one of the cancers that can be prevented if detected early, but ...
The Austrlian government is unlocking the power and potential of personalised medicine with $66 million for genomics res...
Jiahui Health and IASO Biotechnology have announced a deepening of their strategic collaboration to jointly build a ...
In recent years, fluorescence-based lateral flow immunoassay (LFI) has gained popularity as a diagnostic tool for viral ...
MedChem Australia, a first-of-its-kind national initiative connecting three of the nation’s top medicinal chemistr...
US-based biotech firm Moderna, Inc. has announced the launch of the mRNA Platform Incubator Network, a pioneering initia...
Wound management is essential to ensure a speedy and safe recovery, and tissue adhesive patches are an attractive option...
SG Austria (“Austrianova”), a leading provider of cell biological products and services, on 31st Oct an...
US-based startup AnHeart Therapeutics has entered into an exclusive license agreement with Nippon Kayaku to market ...
A local study led by the Agency for Science, Technology and Research (A*STAR) discovered that by inhibiting the function...
LianBio, a biotechnology startup dedicated to bringing innovative medicines to patients in China and other major Asian m...
Australian researchers have been awarded $AU1 million ($687,000) from the US Food and Drug Administration (FDA) to devel...
Diabetic patients, whose natural wound-healing capabilities are compromised, often develop chronic wounds that are slow ...
The Hong Kong Polytechnic University (PolyU) has partnered with Rohto, an eye care brand under Mentholatum, to establish...
A novel glycoengineering platform, created by the researchers at Yong Loo Lin School of Medicine, National University of...
The Australian government is funding ground breaking research that will revolutionise drug development for prostate and ...
UK-based Emergex Vaccines Holding has signed a Memorandum of Understanding with the Saudi Arabia-based startup Vaccine I...
Agilent Technologies Inc. has announced the signing of a Memorandum of Understanding (MoU) with the Sarawak In...
Australian behemoth CSL’s Research Acceleration Initiative (RAI) continues to expand its reach with seven medical ...
Singapore headquarterd biopharmaceutical company DotBio, excelling in antibody therapeutic modalities announced tha...
To better tackle respiratory diseases in Singapore, Nanyang Technological University, Singapore (NTU Singapore) has set ...
Everest Medicines has entered into a collaboration and license agreement with Kezar Life Sciences to develop and commerc...
Engineers at Australia's Monash University have successfully used “bioinks” containing living nerve cells (n...
Agilent Technologies Inc. has signed a Memorandum of Understanding (MoU) with the Advanced Cell Therapy and Research Ins...
Tanoto Foundation has announced a donation of S$1 million to the Singapore National Eye Centre (SNEC) to support a three...
The Broad Institute of MIT (Massachusetts Institute of Technology) and Harvard, in the US, hav...
US-based startup Zenas BioPharma has entered into a license and collaboration agreement with Bristol Myers Squibb Compan...
Australian pharmaceutical company Phebra and the University of Wollongong (UOW) have announced a new six-year collaborat...
Can you provide an overview of TauRx Therapeutics? TauRx is dedicated to research in neurodegenerative diseases and is ...
Singapore-based biopharmaceutical company Specialised Therapeutics Asia (ST) will partner with Netherlands-based biotech...
Researchers from the University of Hong Kong (HKU), the HKU-Shenzhen Hospital and the Princeton University, have collabo...
The Advanced Cell Therapy and Research Institute, Singapore (ACTRIS) launched a new 2,000 sqm cell therapy facility...
A team of scientists from A*STAR’s Genome Institute of Singapore (GIS) and the Yong Loo Lin School of Medicine, Na...
A group led by researchers at Nagoya University in Japan has developed a technology to capture and release cell-free DNA...
On 11 July, 2023, Avantor, Inc., a leading global provider of life sciences and advanced technology solutions, officiall...
A team of scientists led by Nanyang Technological University, Singapore has found that an existing cancer drug could be ...
Hitachi, Ltd. has entered a strategic framework collaboration agreement with the world-renowned medical research institu...
The Health Insurance Review & Assessment Service revealed that over the last year, more than 370,000 Koreans sought ...
Conventional ways of administering medication – by swallowing tablets, consuming bitter syrups, injections o...
China-based CytoNiche Biotechnology, a pioneer in 3D dissolvable porous microcarriers, has opened the Center of Excellen...
Germany-based Centogene, the essential life science partner for data-driven answers in rare and neurodegenerative diseas...
Biosyngen, an immuno-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma tre...
SK bioscience, a global innovative vaccine and biotech company based in South Korea, has signed a collaboratio...
Mixed-reality smart glasses with holographic features are set to revolutionise the treatment of leg and foot wounds for ...
Peruvoside, a plant-based compound that is commonly used to treat heart failure, has been discovered to be able to preve...
Despite decades of intensive cancer research by numerous biomedical scientists, cancer still holds its place as the numb...
The Australian Institute for Infectious Disease (AIID) is a visionary $650 million project supported by the Victorian St...
Indian biotech firm Leucine Rich Bio, South Asia’s first microbiome company, is all set to foray into US healthcar...
The Hong Kong Polytechnic University (PolyU) has joined hands with Tianjin Medical University (TMU), China to nurture ta...
